secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ceribell, Inc. (CBLL)
CIK:        0001861107
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0000950170-25-026668
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ceribell Q4 revenue $18.5M (+41% YoY); FY2024 revenue $65.4M (+45%); guides FY2025 $81-85M
--------------------------------------------------------------------------------

- Q4 revenue $18.5M (+41% YoY); product $14.1M, subscription $4.4M; gross margin 88%.
- FY2024 revenue $65.4M (+45%); net loss $40.5M ($3.39/share) vs $29.5M ($5.56/share) in 2023.
- Cash and equivalents $194.4M at Dec 31, 2024; active accounts 529; over 200,000 patients treated.
- FY2025 revenue guidance $81-85M, representing 24-30% growth over FY2024.
- Submitted 510(k) for pediatric Clarity algorithm; Sean Manni promoted to Chief Revenue Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861107/000095017025026668/0000950170-25-026668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861107/000095017025026668/cbll-20250225.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-026668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer